Literature DB >> 21825871

Emerging role for complement in HIV infection.

Georg Huber1, Zoltán Bánki, Susanne Lengauer, Heribert Stoiber.   

Abstract

PURPOSE OF REVIEW: New evidence is provided that the complement system is not only an effective component of the innate immunity, but is also involved in bridging innate and adaptive immune response to control retroviral infections. RECENT
FINDINGS: The complement contributes to the control of retroviral replication by various strategies, such as complement-mediated lysis, triggering of B-cell responses by trapping the virus on follicular dendritic cells in the germinal center or enhancing of antigen presentation and thus the induction of virus-specific cytotoxic T lymphocytes. HIV has evolved mechanisms to escape from complement-meditated neutralization and counteracts these immune responses by escaping from lysis, using follicular dendritic cells as anchor to generate a latent viral reservoir and enhancing the infection of antigen-presenting cells.
SUMMARY: This review will discuss the complex interactions of complement and complement receptors with retroviruses and review the escape mechanisms, which protect this virus family from complement-mediated destruction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825871     DOI: 10.1097/COH.0b013e3283495a26

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  9 in total

1.  Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.

Authors:  R Herrero; L M Real; A Rivero-Juárez; J A Pineda; Á Camacho; J Macías; M Laplana; P Konieczny; F J Márquez; J C Souto; J M Soria; I Saulle; S Lo Caputo; M Biasin; A Rivero; J Fibla; A Caruz
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

2.  Effects of Well-Controlled HIV Infection on Complement Activation and Function.

Authors:  Alexandria E-B Rossheim; Tina D Cunningham; Pamela S Hair; Tushar Shah; Kenji M Cunnion; Stephanie B Troy
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

3.  Immune regulation and evasion of Mammalian host cell immunity during viral infection.

Authors:  B M Pratheek; Soham Saha; Prasanta K Maiti; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Indian J Virol       Date:  2013-03-15

4.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15

Review 5.  Human immunodeficiency virus vaccines.

Authors:  Paul Goepfert; Anju Bansal
Journal:  Infect Dis Clin North Am       Date:  2014-10-05       Impact factor: 5.982

6.  HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Authors:  Raymond A Alvarez; Rebecca E Hamlin; Anthony Monroe; Brian Moldt; Mathew T Hotta; Gabriela Rodriguez Caprio; Daniel S Fierer; Viviana Simon; Benjamin K Chen
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.

Authors:  Maria E Moreno-Fernandez; Julio Aliberti; Sander Groeneweg; Jörg Köhl; Claire A Chougnet
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-15       Impact factor: 2.205

Review 8.  The role of Fc receptors in HIV prevention and therapy.

Authors:  Austin W Boesch; Eric P Brown; Margaret E Ackerman
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

9.  Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex.

Authors:  Britta Schiela; Sarah Bernklau; Zahra Malekshahi; Daniela Deutschmann; Iris Koske; Zoltan Banki; Nicole M Thielens; Reinhard Würzner; Cornelia Speth; Guenter Weiss; Karin Stiasny; Eike Steinmann; Heribert Stoiber
Journal:  Front Immunol       Date:  2018-10-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.